Death, stroke and major bleeding risk in patients older than 85 years with atrial fibrillation

Back

ESC Premium Access

Death, stroke and major bleeding risk in patients older than 85 years with atrial fibrillation

Session: Antithrombotic therapy in atrial fibrillation 1

Topic: Atrial fibrillation (AF)

Speaker: Doctor Y. Arnson (Kfar Saba, IL)

Event: ESC Congress 2016

Congress Presentation

Add to my library

About the speaker

Doctor Yoav Arnson

Meir Medical Center, Kfar Saba (Israel)

0 follower

5 more presentations in this session

Atrial fibrillation in haemodialysis patients without a vitamin K antagonist: Insight from the RAKUEN study

Speaker: Doctor W. Mitsuma (Niigata, JP)

Access

Abstract

Slides

Short-term risk of haemorrhage during heparin bridging at initiation of vitamin K antagonist therapy in patients with non-valvular atrial fibrillation managed in ambulatory care

Speaker: Doctor K. Bouillon (Saint Denis, FR)

Access

Abstract

Slides

Alcohol abuse is associated with increased risk of ischemic stroke in low risk patients with non-valvular atrial fibrillation.

Speaker: Doctor F. Al-Khalili (Stockholm, SE)

Access

Abstract

Slides

Do baseline characteristics account for geographical variations in event rates in patients with newly diagnosed atrial fibrillation? The GARFIELD-AF registry

Speaker: Professor K. Fox (Edinburgh, GB)

Access

Abstract

Slides

Increased use of oral anticoagulants in patients with atrial fibrillation: Nationwide temporal trends in Denmark from 2005 to 2015

Speaker: Mr K. Gadsboell (Hellerup, DK)

Access

Abstract

Slides

Access the full session

Antithrombotic therapy in atrial fibrillation 1

Speakers: Doctor Y. Arnson, Doctor W. Mitsuma, Doctor K. Bouillon, Doctor F. Al-Khalili, Professor K. Fox...

Access

About the event

ESC Congress 2016

27 August - 31 August 2016

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources